Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis

Rozanna Meijboom(MRC Centre for Regenerative Medicine), Adam Waldman(Royal Society of Edinburgh), Michael J. Thrippleton(MRC Centre for Regenerative Medicine), Mathew A. Harris(University of Edinburgh), Siddharthan Chandran(Edinburgh Royal Infirmary), Agniete Kampaite(University of Edinburgh), Nicole White(University of Edinburgh), Niall MacDougall(MRC Centre for Regenerative Medicine), Peter Connick(University of Cambridge), David Hunt(Mott MacDonald (United Kingdom)), Elizabeth N. York(University of Edinburgh), María Valdés Hernández(Scottish and Southern Energy (United Kingdom))
PLoS ONE
July 28, 2023
10.1371/journal.pone.0288967
Cited by 16

Related Papers

Neuroimaging standards for research into small vessel disease—advances since 2013
|The Lancet Neurology|2023|962
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
|Nature Genetics|2016|639
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study
|The Lancet Neurology|2012|606